Immuneel Therapeutics will utilise the funding round for multiple initiatives that include expanding manufacturing capacity, R&D and international expansion.

The Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a lab to fight cancer, and then put back…

Immuneel Therapeutics will utilise the funding round for multiple initiatives that include expanding manufacturing capacity, R&D and international expansion.